Hospitalized patients with inflammatory bowel disease (IBD) treated using a novel pain management protocol that employs scheduled nonopioid medications adjusted based on pain severity used less opioids in a recent study.
The study also found that the protocol—developed by researchers at Cedars-Sinai, in Los Angeles—was more effective at controlling pain than standard care with opioids (Sci Rep 2023;13[1]:22396).
Pain is a major symptom in most hospitalized IBD patients, and it’s